What's in Fundación EPIC's pipeline?

Fundación EPIC has 3 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Fundación EPIC's portfolio?

Top competitors by shared drug class: Medtronic BRC, University of Parma.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/fundaci-n-epic.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Fundación EPIC — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fundación EPIC pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Previous treatment	Previous treatment	marketed
Essential pro	Essential pro	marketed	Diuretic		Cardiovascular

Therapeutic area mix

Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Medtronic BRC · 1 shared drug class
University of Parma · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Fundación EPIC:

Cite this brief

Drug Landscape (2026). Fundación EPIC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/fundaci-n-epic. Accessed 2026-05-16.